Literature DB >> 1752964

Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia.

C J Mann1, F T Yen, A M Grant, B E Bihain.   

Abstract

Plasma net cholesteryl ester (CE) transfer and optimum cholesteryl ester transfer protein (CETP) activity were determined in primary hypertriglyceridemic (n = 11) and normolipidemic (n = 15) individuals. The hypertriglyceridemic group demonstrated threefold greater net CE transfer leading to enhanced accumulation of CE in VLDL. This increased net transfer was not accompanied by a change in CETP activity. In normolipidemia, but not in hypertriglyceridemia, net CE transfer correlated with VLDL triglyceride (r = 0.92, P less than 0.001). In contrast, net CE transfer in hypertriglyceridemia, but not in normolipidemia, correlated with CETP activity (r = 0.73, P less than 0.01). Correction of hypertriglyceridemia with bezafibrate reduced net CE transfer towards normal and restored the correlation with VLDL triglyceride (r = 0.90, P less than 0.005) while suppressing the correlation with CETP activity. That net CE transfer depends on VLDL concentration was confirmed by an increase of net CE transfer in normolipidemic plasma supplemented with purified VLDL. Supplementation of purified CETP to normolipidemic plasma did not stimulate net CE transfer. In contrast, net CE transfer was enhanced by addition of CETP to both plasma supplemented with VLDL and hypertriglyceridemic plasma. Thus, in normal subjects, VLDL concentration determines the rate of net CE transfer. CETP becomes rate limiting as VLDL concentration increases, i.e., in hypertriglyceridemia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1752964      PMCID: PMC295801          DOI: 10.1172/JCI115535

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 2.  Plasma lipid transfer proteins.

Authors:  A R Tall
Journal:  J Lipid Res       Date:  1986-04       Impact factor: 5.922

Review 3.  Plasma high-density lipoprotein concentration and subfraction distribution in relation to triglyceride metabolism.

Authors:  E A Nikkilä; M R Taskinen; T Sane
Journal:  Am Heart J       Date:  1987-02       Impact factor: 4.749

4.  Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables.

Authors:  R McPherson; C J Mann; A R Tall; M Hogue; L Martin; R W Milne; Y L Marcel
Journal:  Arterioscler Thromb       Date:  1991 Jul-Aug

5.  Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins.

Authors:  M L Brown; A Inazu; C B Hesler; L B Agellon; C Mann; M E Whitlock; Y L Marcel; R W Milne; J Koizumi; H Mabuchi
Journal:  Nature       Date:  1989-11-23       Impact factor: 49.962

6.  Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice.

Authors:  L B Agellon; A Walsh; T Hayek; P Moulin; X C Jiang; S A Shelanski; J L Breslow; A R Tall
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

7.  HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.

Authors:  W P Castelli; J T Doyle; T Gordon; C G Hames; M C Hjortland; S B Hulley; A Kagan; W J Zukel
Journal:  Circulation       Date:  1977-05       Impact factor: 29.690

Review 8.  Factors affecting the rate of catalyzed transfer of cholesteryl esters in plasma.

Authors:  C J Fielding
Journal:  Am Heart J       Date:  1987-02       Impact factor: 4.749

9.  Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma.

Authors:  F T Yen; R J Deckelbaum; C J Mann; Y L Marcel; R W Milne; A R Tall
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

10.  Free cholesterol is a potent regulator of lipid transfer protein function.

Authors:  R E Morton
Journal:  J Biol Chem       Date:  1988-09-05       Impact factor: 5.157

View more
  35 in total

Review 1.  Postprandial lipemia and coronary risk.

Authors:  W Patsch; H Esterbauer; B Föger; J R Patsch
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

2.  Conversion of lipid transfer inhibitor protein (apolipoprotein F) to its active form depends on LDL composition.

Authors:  Richard E Morton; Diane J Greene
Journal:  J Lipid Res       Date:  2011-09-21       Impact factor: 5.922

Review 3.  Postprandial lipemia and cardiovascular disease.

Authors:  Dianne Hyson; John C Rutledge; Lars Berglund
Journal:  Curr Atheroscler Rep       Date:  2003-11       Impact factor: 5.113

4.  Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid.

Authors:  Nicholas B Pike
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

5.  Marine lipids normalize cholesteryl ester transfer in IDDM.

Authors:  J D Bagdade; M Ritter; P V Subbaiah
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

Review 6.  Clinical relevance of reducing triglycerides. Implications for ischaemic heart disease treatment.

Authors:  A N Nafziger
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

Review 7.  The role of CETP inhibition in dyslipidemia.

Authors:  Karim El Harchaoui; Wim A van der Steeg; Erik S G Stroes; John J P Kastelein
Journal:  Curr Atheroscler Rep       Date:  2007-08       Impact factor: 5.113

8.  Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice.

Authors:  L Masucci-Magoulas; P Moulin; X C Jiang; H Richardson; A Walsh; J L Breslow; A Tall
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice.

Authors:  Thomas Gautier; David Masson; Miek C Jong; Jean-Paul Pais de Barros; Linda Duverneuil; Naig Le Guern; Valérie Deckert; Laure Dumont; Amandine Bataille; Zoulika Zak; Xian-Cheng Jiang; Louis M Havekes; Laurent Lagrost
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

10.  Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver.

Authors:  Eliete J B Bighetti; Patrícia R Patrício; Andrea C Casquero; Jairo A Berti; Helena C F Oliveira
Journal:  Lipids Health Dis       Date:  2009-11-23       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.